课题基金 / 基金详情

FRAM 2 FAT REDISTRIBUTION & METABOLIC CHANGE IN HIV INFECTION

FRAM 2 FAT REDISTRIBUTION & METABOLIC CHANGE IN HIV INFECTION
FRAM 2 脂肪重新分配
批准号:
7606562
负责人:
DANIEL LEE
金额:
$0.33万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-12-01 至 2007-11-30

项目摘要

项目成果

DANIEL LEE的其他基金

相似基金

相关文献

中文摘要
翻译
这个子项目是许多利用 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者(PI)可能从另一个NIH来源获得了主要资金, 因此可以在其他CRISP条目中表示。所列机构为 研究中心,而研究中心不一定是研究者所在的机构。 确定HIV感染患者动脉粥样硬化的患病率和动脉粥样硬化的辅助因素,包括传统的HIV独立风险因素,如吸烟、HIV影响的代谢风险因素和与炎症/感染和身体成分相关的新风险因素。
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. To determine the prevalence of atherosclerosis in HIV infected patients and co-factors of athersclerosis including traditional HIV-independent risk factors such as smoking, HIV-influenced metabolic risk factors and novel risk factors relating to inflammation/infection and body composition.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CLINICAL TRIAL: ACTG A5229 TRIAL OF URIDINE SUPPLEMENTATION IN HIV LIPOATROPHY
CLINICAL TRIAL: ACTG A5229 TRIAL OF URIDINE SUPPLEMENTATION IN HIV LIPOATROPHY
海外基金